Hao D - Search Results

1

Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome.

Hao D, Li J, Wang J, Meng Y, Zhao Z, Zhang C, Miao K, Deng C, Tsang BK, Wang L, Di LJ. Hao D, et al. Theranostics. 2019 May 31;9(13):3952-3965. doi: 10.7150/thno.30814. eCollection 2019. Theranostics. 2019. PMID: 31281524 Free PMC article.

2

Distinct mutation accumulation rates among tissues determine the variation in cancer risk.

Hao D, Wang L, Di LJ. Hao D, et al. Sci Rep. 2016 Jan 20;6:19458. doi: 10.1038/srep19458. Sci Rep. 2016. PMID: 26785814 Free PMC article.

3

Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.

Wang Y, Hao DP, Li JJ, Wang L, Di LJ. Wang Y, et al. Oncotarget. 2017 Jul 4;8(27):44705-44719. doi: 10.18632/oncotarget.18348. Oncotarget. 2017. PMID: 28621677 Free PMC article.

4

Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy.

Li J, Hao D, Wang L, Wang H, Wang Y, Zhao Z, Li P, Deng C, Di LJ. Li J, et al. Among authors: hao d. Sci Rep. 2017 Jun 22;7(1):4035. doi: 10.1038/s41598-017-04406-0. Sci Rep. 2017. PMID: 28642588 Free PMC article.

5

Integrated Analysis Reveals Tubal- and Ovarian-Originated Serous Ovarian Cancer and Predicts Differential Therapeutic Responses.

Hao D, Li J, Jia S, Meng Y, Zhang C, Wang L, Di LJ. Hao D, et al. Clin Cancer Res. 2017 Dec 1;23(23):7400-7411. doi: 10.1158/1078-0432.CCR-17-0638. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939742

6

Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity.

Hao D, Liu J, Chen M, Li J, Wang L, Li X, Zhao Q, Di LJ. Hao D, et al. Clin Cancer Res. 2018 Aug 1;24(15):3560-3571. doi: 10.1158/1078-0432.CCR-17-3862. Epub 2018 Apr 16. Clin Cancer Res. 2018. PMID: 29661778

7

CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling.

Zhao Z, Hao D, Wang L, Li J, Meng Y, Li P, Wang Y, Zhang C, Zhou H, Gardner K, Di LJ. Zhao Z, et al. Among authors: hao d. Oncogene. 2019 Mar;38(12):2076-2091. doi: 10.1038/s41388-018-0570-z. Epub 2018 Nov 15. Oncogene. 2019. PMID: 30442980

8

miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.

Wang T, Hao D, Yang S, Ma J, Yang W, Zhu Y, Weng M, An X, Wang X, Li Y, Wu D, Tang J, Yang C, He Y, Zhang L, Jin X, Wang G, Li Z, Zheng T, Meng H, Feng Y, Li X. Wang T, et al. Among authors: hao d. Cell Death Dis. 2019 Jun 24;10(7):495. doi: 10.1038/s41419-019-1715-x. Cell Death Dis. 2019. PMID: 31235732 Free PMC article.

9

Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancer.

Hao D, Wang G, Yang W, Gong J, Li X, Xiao M, He L, Wang L, Li X, Di L. Hao D, et al. Int J Biol Sci. 2019 Jul 21;15(9):1933-1941. doi: 10.7150/ijbs.33297. eCollection 2019. Int J Biol Sci. 2019. PMID: 31523194 Free PMC article.

10

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.

Wang H, Guo S, Kim SJ, Shao F, Ho JWK, Wong KU, Miao Z, Hao D, Zhao M, Xu J, Zeng J, Wong KH, Di L, Wong AH, Xu X, Deng CX. Wang H, et al. Among authors: hao d. Theranostics. 2021 Jan 1;11(5):2442-2459. doi: 10.7150/thno.46460. eCollection 2021. Theranostics. 2021. PMID: 33500735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,799 results

Search Page

Filters